In December 2023, back when the ink was still drying on the amendments to Federal Rule of Evidence 702, the Southern District of New York excluded all five general causation experts proffered by plaintiffs in the In re Acetaminophen MDL whose cases had been selected for trial. We discussed that impressively detailed and painstaking decision … Continue reading “Plaintiffs’ Second Bite at the General Causation Apple Fares No Better Than the First in Acetaminophen MDL”